Shared on 04 Aug 25
Fair value Decreased 7.70%Despite a modest improvement in consensus revenue growth forecasts, IDEX's fair value has been revised downward—reflected in a lower analyst price target—amid a notable drop in its expected future P/E multiple. What's in the News IDEX is actively seeking tuck-in M&A opportunities focused on scaling and expanding capabilities in key markets while maintaining organic investments as its top capital allocation priority.
Shared on 30 Apr 25
Fair value Increased 0.96%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 23 Apr 25
Fair value Decreased 1.66%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 16 Apr 25
Fair value Decreased 4.36%AnalystConsensusTarget has decreased revenue growth from 5.9% to 5.2%.
Shared on 09 Apr 25
Fair value Decreased 3.00%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Decreased 0.72%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 10 Mar 25
Fair value Increased 10%AnalystConsensusTarget has decreased revenue growth from 7.7% to 6.1%, decreased profit margin from 20.1% to 17.7% and increased future PE multiple from 26.6x to 31.6x.